10-QPeriod: Q1 FY2022

CME GROUP INC. Quarterly Report for Q1 Ended Mar 31, 2022

Filed May 4, 2022For Securities:CME

Summary

CME Group Inc. reported strong financial results for the first quarter of 2022, demonstrating robust revenue growth and improved profitability. Total revenues increased by 7% year-over-year to $1.35 billion, primarily driven by a significant 13% rise in clearing and transaction fees to $1.14 billion. This growth in core business revenue was fueled by a 21% increase in total contract volume, with notable surges in interest rate and equity index products, reflecting heightened market volatility. The company also saw a 5% increase in market data and information services revenue. Despite increased revenues, total expenses saw a decrease of 8% to $487.5 million, leading to an expansion in operating margin from 57.9% to 63.8%. This reduction in expenses was mainly due to lower compensation and benefits costs, partly offset by an increase in licensing and other fee agreements. Net income attributable to CME Group grew by a substantial 24% to $711.0 million, resulting in diluted earnings per common share of $1.95, up from $1.60 in the prior year's quarter. The company also maintained a strong liquidity position and declared a quarterly dividend of $1.00 per share.

Financial Highlights

45 data points
Beta

Revenue

$1.35B

Net Income

$711.00M

52.8% Net Margin

EPS (Diluted)

$1.95

Total Assets

$205.92B

Cash & Equivalents

$2.05B

Free Cash Flow

$775.70M

Financial Statements
Beta
Revenue$1.35B
Operating Expenses$487.50M
Operating Income$859.10M
Net Income$711.00M
EPS (Basic)$1.96
EPS (Diluted)$1.95
Shares Outstanding (Basic)358.61M
Shares Outstanding (Diluted)359.18M

Key Highlights

  • 1Total revenues increased by 7% to $1.35 billion in Q1 2022 compared to Q1 2021.
  • 2Clearing and transaction fees, the primary revenue driver, grew by 13% to $1.14 billion.
  • 3Total contract volume surged by 21% year-over-year, indicating increased market activity and volatility.
  • 4Interest rate and equity index products showed significant volume increases (21% and 30% respectively), driven by macroeconomic factors and geopolitical events.
  • 5Operating expenses decreased by 8% to $487.5 million, contributing to an improved operating margin.
  • 6Net income attributable to CME Group increased by 24% to $711.0 million.
  • 7Diluted earnings per share rose to $1.95 from $1.60 in the prior year's quarter.

Frequently Asked Questions

The primary driver for the revenue increase was a 13% rise in clearing and transaction fees, which reached $1.14 billion. This was supported by a significant 21% increase in total contract volume, particularly in interest rate and equity index products, reflecting heightened market volatility. Additionally, market data and information services revenue grew by 5%.

Operating expenses decreased by 8% primarily due to lower compensation and benefits costs. This reduction was influenced by a net decrease in headcount, including employees transferred to the OSTTRA joint venture, and lower employee separation costs. While licensing and other fee agreements increased, the overall expense reduction contributed to margin expansion.

CME Group maintained a strong liquidity position, with cash and cash equivalents totaling $2.0 billion at March 31, 2022. The company has significant borrowing capacity available through its revolving credit facilities. In March 2022, it issued $750 million in new notes and used the proceeds to redeem existing notes. The company expects to maintain its investment-grade credit rating.

The report indicates that increased market volatility stemming from macroeconomic factors (like Federal Reserve interest rate policy) and geopolitical events (such as the situation in Russia and Ukraine) led to higher contract volumes in the first quarter of 2022. While the report doesn't provide future guidance, these trends suggest continued activity, though future performance will depend on ongoing market conditions and competitive dynamics.